---
schema_version: "secwatch.filing_event.v1"
accession: "0001279569-26-000827"
form_type: "8-K"
ticker: "GRUSF"
cik: "0001463000"
company_name: "Grown Rogue International Inc."
filed_at: "2026-08-25T19:50:50+00:00"
generated_at: "2026-08-25T19:52:18.661019+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Grown Rogue enters NY via JV, $15M financing commitment, plans PharmaCann NY acquisition

## Summary
- Grown Rogue New York JV: capital partner invests $10M for 49% preferred equity; Grown Rogue holds 51%.
- Planned purchase price ~$4.5M ($3M at regulatory approval); plus $5M drawable term loan at 15%, $9M secured loan to PCNY.
- Targets: 4 Verilife dispensaries (avg $1.7-2.0M monthly sales) and Hamptonburgh facility with 24,000 sq ft indoor + 16,000 sq ft greenhouse canopy.
- Preferred equity convertible to ~18.2M SVS (~7% dilution) at $0.55-0.76/share; commitment fee 300K shares + 0.901 warrants per $1 drawn.
- Expects NY operations cash-flow positive within 9 months, ~$600K monthly after-tax CF within 18 months; ~$20M annual cost reductions.

## SEC filing metadata
- accession: 0001279569-26-000827
- form_type: 8-K
- ticker: GRUSF
- cik: 0001463000
- company_name: Grown Rogue International Inc.
- filed_at: 2026-08-25T19:50:50+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1463000/000127956926000827/0001279569-26-000827-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1463000/000127956926000827/grownrogue8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001279569-26-000827
- JSON: https://secwatch.observer/filing/0001279569-26-000827.json
- Plain text: https://secwatch.observer/filing/0001279569-26-000827.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.